Smad3对促肾上腺皮质激素分泌型垂体腺瘤发生、细胞增殖、凋亡及激素分泌的影响
该研究检测了5例正常前垂体和18例促肾上腺皮质激素分泌型垂体腺瘤(ACTH-PAs)中Smad3、pSmad3及Smad2的表达,并在AtT-20细胞中上調或下調Smad3,观察对增殖、凋亡、ACTH分泌及BCL-2、POMC表达的影响。结果显示ACTH-PAs中Smad3和pSmad3表达降低而Smad2不变;过表达Smad3抑制增殖、促进凋亡、减少ACTH分泌,敲低则相反。作者认为Smad3在ACTH-PAs中低表达,恢复其表达可抑制肿瘤生长并减少ACTH分泌。
要点
- ACTH-PAs中Smad3和pSmad3表达降低,Smad2水平不变。
- 过表达Smad3抑制AtT-20细胞增殖、促进凋亡并减少ACTH分泌。
- Smad3敲低增加增殖、减少凋亡,但对ACTH分泌无显著影响。
核心结论
- Smad3在ACTH-PAs中低表达。
- 在AtT-20细胞中逆转Smad3表达可抑制细胞生长、促进肿瘤凋亡并减少ACTH分泌。
- 肿瘤抑制可能通过促进pSmad3及降低BCL-2和POMC表达介导。
研究设计与样本
- 检测5例正常前垂体和18例ACTH-PAs样本中Smad3、pSmad3和Smad2蛋白表达(Western blot和免疫组化)。
- 体外用Smad3-CMV质粒上調或小干扰RNA下調AtT-20细胞中Smad3表达,检测细胞增殖、凋亡、ACTH水平及pSmad3、BCL-2、POMC蛋白表达。
主要发现
- 与正常垂体相比,ACTH-PAs中Smad3和pSmad3表达降低,Smad2水平不变。
- 体外过表达Smad3抑制细胞增殖、促进细胞凋亡并减少ACTH分泌。
- Smad3敲低增加细胞增殖、减少细胞凋亡,但对ACTH分泌无显著影响。
- 过表达Smad3增加pSmad3但抑制BCL-2和POMC蛋白表达;Smad3低表达则抑制pSmad3但促进BCL-2和POMC蛋白表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Down-regulation of mothers against decapentaplegic homolog 3 (Smad3) results in the formation of tumors both in vivo and in vitro. However, little is known about the effect of Smad3 on adrenocorticotropic hormone-secreting pituitary adenomas (ACTH-PAs). Our objective was to study the expression and effect of Smad3 in ACTH-PAs and its possible mechanisms. METHODS: Smad3, COOH-terminally phosphorylated mothers against decapentaplegic homolog 3 (pSmad3), and mothers against decapentaplegic homolog 2 proteins (Smad2) were detected in samples from 5 normal anterior pituitaries and 18 ACTH-PAs by Western blot and immunohistochemical analysis. Then, Smad3 expression was up-regulated by Smad3-CMV plasmid or down-regulated by small interfering RNA in ACTH tumor cells (AtT-20) in vitro. Cell proliferation, apoptosis, ACTH level, and pSmad3, B-cell lymphoma/lewkmia-2 (BCL-2), and pro-opiomelanocortin (POMC) protein expression in the AtT-20 cells were measured to investigate the antitumor effects of Smad3. RESULTS: Reduced expression of Smad3 and pSmad3 but unchanged Smad2 levels were found in ACTH-PAs compared with normal pituitaries. In vitro, the overexpression of Smad3 inhibited cell proliferation, promoted cell apoptosis, and decreased ACTH secretion; in contrast, Smad3 knockdown increased cell proliferation and decreased cell apoptosis but had no significant effect on ACTH secretion. At the same time, overexpression of Smad3 increased pSmad3 but inhibited BCL-2 and POMC protein expression. On the contrary, underexpression of Smad3 inhibited pSmad3 but promoted BCL-2 and POMC protein expression. CONCLUSIONS: Smad3 is underexpressed in ACTH-PAs. Reversing the expression of Smad3 in AtT-20 cells could suppress cell growth, promote tumor apoptosis, and decrease ACTH secretion. Tumor suppression was possibly mediated by the promotion of pSmad3 and the reduction of BCL-2 and POMC expression.
引用
- Zhou YZ, Li CZ, Gao H, et al. The Effects of Smad3 on Adrenocorticotropic Hormone-Secreting Pituitary Adenoma Development, Cell Proliferation, Apoptosis, and Hormone Secretion. World Neurosurg. 2018. PMID: 29524699. doi:10.1016/j.wneu.2018.02.181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。